Essentials of Statins for Lipid-Lowering Drug Use: Characteristics of Common Varieties, Adverse Reaction Monitoring, and Prevention of Myopathy Risk

What are some commonly used statin lipid-lowering drugs? What are their characteristics? How are they used?

① Lovastatin: Brand name: Mevacor. It was the first statin drug to be marketed. It reduces cholesterol synthesis, lowers LDL cholesterol, increases HDL cholesterol, and lowers triglycerides. It is also effective for patients with mixed dyslipidemia, primarily characterized by elevated cholesterol. Additionally, it can promote the regression of atherosclerotic lesions. The usual dosage is 10-20 mg after dinner daily. If no significant effect is observed after 4 weeks of continuous use, the dosage can be increased to 40 mg, with a maximum daily dose not exceeding 80 mg.

② Simvastatin: Brand name: Simvastatin. This drug has twice the inhibitory effect on HMG-CoA reductase as lovastatin; at the same dose, its cholesterol-lowering effect is slightly stronger than lovastatin. This product moderately lowers TG and raises HDL-C. Efficacy is seen after 2 weeks of treatment, peaking at 4-6 weeks. The usual dose is 10-20 mg once daily, taken with dinner (to facilitate absorption), with a maximum daily dose not exceeding 80 mg.

③ Pravastatin: Brand name Pravastatin. This product has the same effect as lovastatin. Oral administration of 10 mg and 20 mg daily can reduce LDL-C by 20% and 31%, respectively, although its effect is weaker than lovastatin. Pravastatin also has unique non-lipid-lowering effects, stabilizing plaques, reducing platelet thrombus formation, restoring endothelial function, and reducing inflammatory responses, thus protecting the heart. Due to these effects, it can prevent and treat coronary atherosclerosis and coronary heart disease. This product is mainly used for hypercholesterolemia that cannot be controlled by diet alone. Oral administration: 10 mg daily, once daily or divided into two doses. The maximum dose is 20 mg daily.

④ Fluvastatin: Brand name: Lescol. In patients with hypercholesterolemia and mixed dyslipidemia, this drug can reduce total cholesterol, LDL cholesterol, and triglyceride levels, and increase HDL cholesterol levels. Good therapeutic effects are observed within two weeks of use. Additionally, this drug can slow the progression of coronary atherosclerosis. The usual dose is 20-40 mg once daily, taken with dinner or at bedtime.

⑤ Atorvastatin: Brand name: Lipitor. This is a novel synthetic statin, the most widely used lipid-lowering drug worldwide. Its effect on lowering TC and LDL-C is superior to the aforementioned statins. It has a significant lipid-lowering effect by blocking the production of cholesterol esters in the liver, thereby lowering blood cholesterol, especially LDL-C. In addition, it has anti-atherosclerotic effects, reducing lipid infiltration and foam cell formation, stabilizing plaques, and preventing atherosclerotic plaque rupture. Therefore, it is used to treat hypercholesterolemia and mixed hyperlipidemia, and also for the prevention and treatment of coronary heart disease and stroke. The usual adult dose is 10-20 mg orally once a day with dinner. The dosage can be adjusted as needed, but the maximum dose should not exceed 80 mg per day.

What are the adverse reactions of statins?

Most people tolerate statins well. Common adverse reactions include headache, insomnia, depression, and gastrointestinal symptoms such as indigestion, diarrhea, abdominal pain, and nausea. The main adverse reactions are twofold: damage to the liver and muscles. Approximately 10% of patients taking statins will experience elevated liver transaminase levels, which can rise to more than three times the normal value. Higher doses increase the likelihood of elevated transaminase levels, while lower doses decrease the likelihood. In cases of elevated transaminase levels, if the medication is discontinued immediately, levels usually return to normal within 2-3 months. The most serious adverse reaction of statins is myopathy, including myalgia, myositis, and rhabdomyolysis. Myalgia manifests as muscle pain or weakness without elevated creatine kinase (CK). Myositis presents with myalgia and elevated CK. Rhabdomyolysis refers to muscle symptoms accompanied by a significant increase in CK levels exceeding 10 times the upper limit of normal, often accompanied by brown urine and myoglobinuria, and may even lead to acute renal necrosis, which can be fatal in severe cases. What is myopathy caused by statin lipid-lowering drugs?

One of the adverse reactions of statin lipid-lowering drugs is the induction of myopathy. Myopathy is a disease involving the muscles and can be acquired or hereditary. Myopathy damages muscle tissue, and in most cases, it affects muscles throughout the body. Myositis is a common type of myopathy, and myalgia is one of its symptoms. Myalgia involves only muscle pain or weakness without elevated creatine kinase levels; myositis, however, presents with both myalgia and elevated creatine kinase. The vast majority of myopathy first appears in areas near the trunk, such as the chest muscles, the bony ends of the upper limbs, and the thigh muscles, and can potentially develop into rhabdomyolysis. Patients experiencing myalgia after taking statins should immediately inform their doctor.

What is rhabdomyolysis caused by statins? When a patient develops myopathy after taking statins, and the patient does not take it seriously or the doctor fails to diagnose it correctly, continuing to take the medication may further lead to muscle breakdown and kidney failure, i.e., rhabdomyolysis. This disease can cause kidney damage due to toxic substances produced by muscle cells. Symptoms include myalgia, accompanied by a significant increase in creatine kinase (CK), exceeding the upper limit of normal (15-105 U/L for men, 10-80 U/L for women) by more than 10 times, elevated creatinine, and the appearance of brown urine and myoglobinuria. Myoglobin is an iron-containing pigment in skeletal muscle. When skeletal muscle is damaged, myoglobin is released into the bloodstream. Myoglobin is filtered by the kidneys, which may clog kidney tissue. Myoglobin also breaks down into certain toxic substances, leading to kidney failure and death. The incidence of rhabdomyolysis is 1/10,000, and it can occur at any age, sex, and race.

How to prevent myopathy caused by statins? The following points should be noted to prevent myopathy caused by statins:

① Strictly adhere to the indications: This drug should only be considered when other therapies are ineffective and cholesterol levels exceed 7.8 mmol/L.

② Start with a low dose: Begin with a low dose, adjusting the medication over approximately 4 weeks. Especially when increasing the dose, a gap of at least 4 weeks is necessary.

③ Creatine kinase (CK) should be measured before starting medication, especially for patients over 70 years of age.

④ If muscle pain or weakness occurs during medication, drug-induced myopathy should be considered. Inform your doctor immediately and discontinue the medication.

What are the clinical implications of elevated creatine kinase (CK) levels caused by statin lipid-lowering drugs? The incidence of muscle discomfort varies among different statins, with severe cases occurring at a very low rate (<10/1,000,000). Except for patients susceptible to myopathy, CK testing is not always necessary. For patients with tolerable muscle pain and weakness, and CK elevation less than 5 times the normal value (mild elevation), the original dose can be maintained or reduced. For patients with CK elevation greater than 5 times the normal value (moderate elevation), medication should be discontinued. For patients with severe myalgia or weakness, regardless of CK levels, statin lipid-lowering drugs should be discontinued. After symptoms subside, a small dose can be tried again, or alternative medications can be used. Muscle damage most frequently occurs in patients with multiple comorbidities and/or those using multiple medications. The incidence of myositis increases when using high-dose statins or in combination with other drugs, including fibrates, niacin, macrolides, cyclosporine, and certain antirheumatic drugs. Therefore, CK levels should be measured when using these medications. In rhabdomyolysis, CK levels are significantly elevated, exceeding 10 times the upper limit of normal, along with elevated creatinine, often accompanied by brown urine and myoglobinuria.

What precautions should be taken when taking statin lipid-lowering drugs? There are some specific precautions to be aware of when taking statin lipid-lowering drugs.

① Understand the patient's condition: Does the patient have any coexisting liver or kidney dysfunction, hypothyroidism, or other diseases? Has the patient recently undergone major surgery? Are there any contraindications listed in the drug's instructions, or have they consumed any medications or foods that may cause adverse reactions (such as grapefruit juice)?

② Medication timing: Statins are best taken in the evening. The cholesterol-lowering effect is greater when taken at night than during the day.

③ Avoid combining with fibrates such as gemfibrozil: While combined use can enhance its triglyceride-lowering effect, it can also significantly increase the incidence of myalgia. The incidence of myalgia is only 0.1% when used alone, but 5% when used in combination. Similarly, avoid combining with imidazole antifungals (such as ketoconazole), macrolides (such as roxithromycin), calcium channel blockers (such as thiamethoxam), verapamil, and certain foods (such as grapefruit juice). ④ Monitoring of adverse reactions: Before taking statins, transaminase and creatine kinase levels should be tested. These levels should be tested again every 4-6 weeks during treatment. If any abnormalities are found, discontinue use immediately and report to your doctor.

⑤ Pay attention to any reactions: Observe for muscle pain, discomfort, fatigue, and dark brown urine. If any occur, consult your doctor promptly.

⑥ Recheck blood lipids and adjust dosage: Blood lipids should be checked one month after starting medication. If the target level has been reached, continue taking the medication at the original dosage; if the target level has not been reached, the dosage needs to be adjusted or other lipid-lowering drugs should be considered. Do not arbitrarily increase or decrease the dosage.

⑦ Statins are contraindicated in pregnant and breastfeeding women.

⑧ Statins are contraindicated in patients with active or chronic liver disease.

What kind of patients need statins? Statins can be used by patients with hypercholesterolemia, mixed hyperlipidemia with elevated cholesterol as the main symptom, arteriosclerosis, and coronary heart disease.

Which patients should not take statins? Statins are primarily metabolized in the liver; therefore, they are contraindicated in patients with cholestasis, active liver disease, or persistently elevated transaminases of unknown cause. Because statins can cause fetal maldevelopment in animal studies, they are contraindicated in pregnant women. It is unclear whether statins are excreted in breast milk; therefore, they are not recommended for breastfeeding women. Patients allergic to one type of statin should use other statins with caution.

What precautions should be taken to avoid or reduce the adverse reactions of statins?

To better reduce and avoid the adverse reactions of statins, the following should be observed:

① Strictly adhere to the indications and contraindications of these drugs, and avoid easily expanding the treatment scope or increasing the dosage;

② Closely monitor for possible adverse reactions during use, and be highly vigilant for potential adverse reactions.